CCMAS Course Search
Browse BRIDGE's courses under the National Universities Commission's Core Curriculum Minimum Academic Standards (CCMAS) — Nigeria's unified benchmark curriculum for every accredited program. Search by course title, code, faculty or programme to see full descriptions, learning outlines and credit-hour loads.
4,624
Courses
10
Faculties
168
Programmes
Faculty: Medicine and Dentistry ×
Programme: Bachelor of Medicine and Bachelor of Surgery (MBBS/MBChB) ×
Clear all filters
Showing 11–20
of 221 courses
PHS 203
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. classify the composition and functions of blood; 2. enumerate plasma proteins, albumin, globulin fibrinogen, and their functions; 3. explain red blood cells forma...
View learning outline
General characteristics and functions of blood. Properties and functions of plasma. Red blood
cells factors involved in erythropoiesis, blood groups. White blood cells, origin, type,
properties, functions, antigenicity and immunities. Platelets and hemostatic mechanisms.
Reticulo-endothelial system. Clotting and fibrinolytic systems. Immunity and
immunodeficiency disease and HIV.
HAE 402
2 Unit(s) (LH 15; PH 45)
At the end of this course, students should be able to: 1. list indications for blood transfusion and explain methods of blood storage, anticoagulants and shelf-lives; 2. describe blood component preparation, indications,...
View learning outline
Introduction to red blood cell serology. Antigens and antibodies of ABO and Rh blood group
systems, haemolytic diseases of foetus and newborn. Blood donation. Donor recruitment
including criteria for acceptance and deferrals for allogenic blood donors. Blood collection and
screening for TTIs including HIV–screening and window period. Clinical blood transfusion.
Indications for blood transfusionn, blood storage, blood fractionation and component therapy,
rational use of blood, blood compatibility testing, bedside pre-transfusion check. Complications
of blood transfusion and management. Immediate, delayed, immunological and non-
immunological.
BCH 203
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. explain classification and chemistry of carbohydrate; 2. discuss chemistry and biochemistry of the polysaccharide including the amino sugars; mucopolysaccharides,...
View learning outline
Classification and chemistry of carbohydrate. Chemistry and biochemistry of the
polysaccharide including the amino sugars, mucopolysaccharides, blood group substances.
BCH 208
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. outline glycolysis (Embden- Meyerhof pathway), aerobic and anaerobic phases; 2. explain the control mechanisms and substrate level phosphorylation; 3. illustrate...
View learning outline
Glycolysis (Embden- Meyerhof pathway), aerobic and anaerobic phases. Control mechanisms
and substrate level phosphorylation. The kerb’s cycle/citric acid cycle. Metabolism of galactose
and fructose the uronic acid pathway gluconeogenesis, glycogenesis and glycogenolysis. The
HMP shunt and its biochemical importance.
MED 405
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. demonstrate knowledge and skills in cardiology; 2. recognise and manage common cardiac diseases especially in our environment; 3. respond to cardiovascular emerge...
View learning outline
Approach to the evaluation of the cardiac patients and common symptomatology in
cardiovascular diseases. Chest pain. Dyspnoea. Orthopnoea. Paroxysmal nocturnal dyspnoea
and palpitations. Approach to cardiovascular system examination, the precordium, valvular
areas, heart sounds and murmurs. Introduction to common cardiovascular diseases,
hypertension, heart failure (epidemiology, clinical features, mechanisms/pathophysiology,
investigation and diagnosis). Introduction to ECG.
MED 606
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. demonstrate sound theoretical knowledge of the subject; 2. list and display sound clinical skills in the evaluation of the cardiac patient; 3. investigate patient...
View learning outline
Pathological functional sates of the heart: systolic and diastolic dysfunction; arrhythmias;
ischaemic heart diseases. Cardiomyopathies. Dilated, restrictive and hypertrophic. Peripheral
vascular diseases. Acute and chronic arterial diseases, embolic diseases, venous
thromboembolism. CVS infections. Congenital abnormalities. Valvular abnormalities.
Emergencies in cardiology.
SUG 603
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. enumerate symptoms and signs of common lesions in cardiothoracic and vascular surgery; 2. discuss chest trauma and chest wall tumours; 3. explain principles of ma...
View learning outline
Symptoms and signs of common lesions in cardiothoracic and vascular surgery, including their
interpretations. Chest trauma and chest wall tumours. Introduction to principles of
management of common lesions in cardiothoracic surgery including relevant investigations,
treatment and complications. Congenital malformations and their management.
PAE 503
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. define the cardiovascular system; 2. enumerate the classification of CVS disorders; 3. enumerate the general examination findings of a child with cardiovascular l...
View learning outline
Evaluation of the cardiovascular system, epidemiology and aetiology of common
cardiovascular disorders. Classification of CVS disorders. General examination findings of a
child with cardiovascular lesion. Examination of the peripheral pulses. Blood pressure
measurement. Jugular venous pressure measurement, examination of the precordium. The
role of chest radiograph, ECG and echocardiography in the diagnosis of common CVS
disorders. Congenital heart disease I. Classification of acyanotic congenital heart diseases.
Pathophysiology and clinical features of ventricular septal defects (VSD), atrial septal defects
(ASD) and persistent ductus arteriosus (PDA). To recognise the peculiar clinical features of
VSD, ASD and PDA. The role of chest radiograph, ECG and echocardiography in the diagnosis
of VSD, ASD and PDA. Medical treatment, intervention cardiology and the role of surgery in
the management of acyanotic heart disease. Congenital heart diseases II. Classification of
cyanotic congenital heart diseases. Pathophysiology and clinical features of cyanotic
congenital heart diseases. To recognise the peculiar clinical features of tetralogy of fallot
(TOF). Clinical features and management of hypercyanotic spells. The role of chest
radiograph, ECG and echocardiography in the diagnosis of TOF. Typical chest radiograph, ECG
and ECHO findings of common cyanotic CHDs. Medical treatment, intervention and the role
of surgery in the management of cyanotic congenital heart disease. Heart failure in infancy
and childhood, definition, pathophysiology, signs and symptoms, causes by age, management.
Acquired heart diseases, acute rheumatic fever. Rheumatic valvular heart disease.
Cardiomyopathy. Infective endocarditis. Myocarditis. Pericarditis. Kawasaki disease.
Evaluation of the respiratory system, brief anatomy and physiology of the respiratory system.
Basic principle in history taking of the respiratory system. Steps in general physical
examination relating to the respiratory system. Examination of the respiratory system.
Investigation of the respiratory system. Communication. Disorders of the upper respiratory
tract. Definition of the upper airway. Classification of disorders of the upper airway. History
and common clinical presentations, investigations, communication. Asthma and chronic
116
respiratory disorders. Definition of asthma, mechanism/pathophysiology, history
taking/presentation, investigation, treatment, prevention, communication. The wheezing
child.
PCL 306
3 Unit(s) (LH 30; PH 45)
At the end of this course, students should be able to: 1. describe electrophysiology of normal cardiac rhythms and mechanism of arrhythmias; 2. enumerate the classes of drugs used in management, with specific drug exampl...
View learning outline
Hypertension and blood pressure regulation. Aetiology of hypertension. Normal regulation of
blood pressure. Postural baroreflex. Renal response to decreased blood pressure, therapeutic
implications, diagnosis. Basic pharmacology of antihypertensive drugs in relation to
mechanism and site of action, haemodynamic effects, dosage, pharmacokinetics and toxicity,
diuretics, sympatholytic drugs, direct vasodilator, and drugs that block production or action of
angiotensin. Angina pectoris and anti-anginal Drugs. Pathophysiology of angina, determinants
of coronary blood flow and myocardial oxygen supply, specific therapeutic interventions
(nitrates, beta blockers, calcium entry blockers). Basic and Clinical pharmacology of anti-
anginal drugs. Historical concepts, chemistry, pharmacokinetics, pharmacodynamics, toxicity
and tachyphylaxis. Congestive heart failure and Drugs used in Management, pathophysiology
of heart failure, pathophysiology of cardiac performance, pathophysiology of the peripheral
vasculature in congestive heart failure. Basic and clinical pharmacology of drugs used in
congestive heart failure (cardiac glycosides and others like amrinone and beta-adrenergic
stimulants), Administration, dosage, interactions, other clinical uses, toxicity, chemistry,
pharmacokinetics, pharmacodynamics (mechanical and electrical effects). Cardiac arrhythmias
and anti-arrhythmic drugs, electrophysiology of normal cardiac rhythm, mechanisms of
arrhythmias. Basic and clinical pharmacology of anti-arrhythmic drugs, classes and types,
mechanism of action, specific drugs, pharmacokinetics, pharmacodynamics and extracardiac
effects, principles of anti-arrhythmia. Diuretics, renal tubule transport mechanism. Proximal
and distal tubules, loop of Henle and collecting ducts. Basic and clinical pharmacology -types
(carbonic anhydrase inhibitors, thiazides, loop diuretics, potassium-sparing (aldosterone
antagonist), chemistry, pharmacokinetics, pharmacodynamics, clinical indications, dosage,
toxicity, contraindications, combination therapy. Drugs that affect water excretion. Mannitol.
Clinical pharmacology of diuretics - Oedematous state (CHF, hepatic cirrhosis, nephritic
syndrome) non-oedematous states (hypertension, renal potassium wasting), alteration of
urinary pH, tract infections, renal failure immunity, immunosuppressive drugs. Drugs used in
79
hyperlipidaemic conditions, Pathophysiology of hyperlipoproteinemia, Normal lipoprotein
metabolism review, the hyperlipoproteinemic states (primary hypertriglyceridemia, primary
hypercholesterolaemia, deficiency of high-density lipoproteins, secondary
hyperlipoproteinemia). Role of elevated serum LDL concentrations in promoting risk of
developing cardiovascular disease, protective role of increased serum HDL concentration in
decreasing risk, presently accepted values for desirable LDL, HDL and triglyceride
concentrations in normal individuals, treatment goals for individuals with hyperlipidaemia. Role
of diet and lifestyle, pharmacology of specific drugs used (nicotinic acid, clofibrate, gemfrozil,
bile acid-binding resins, sitosterols, neomycin, HMG-CoA reductase inhibitors, dextrothyroxine,
probucol), drug combinations. Drugs Acting on blood. Cytopenia and Drugs used in treatment
anaemias. Iron deficiency and other hypochromic anaemias, megaloblastic anaemia, basic
pharmacology of drugs used in management, iron, cobalamins (B12), folates. Basic
pharmacology, clinical indication, mechanism of action, adverse effects and contraindications
of the growth factors used in management of cytopenia, including, erythropoietin, G-CSF, GM-
CSF and IL-II. thrombosis and thrombolytics, principles of blood coagulation, plasma
coagulation factors, regulation of coagulation and fibrinolysis. Basic pharmacology of drugs
used to treat thrombosis, types of anti-coagulants (heparin and low molecular weight heparins,
coumarins, indandiones), chemistry, pharmacokinetics, mechanism of action, administration
and dosage, role of aPTT in heparin monitoring, concept of using INR in management of
warfarin therapy. Platelet aggregation inhibitors, drugs that inhibit platelet function, aspirin
and related cyclooxygenase inhibitors, imidazole, sulphinpyrazone. Drugs used in bleeding
disorders. Vitamin K. Factor VIII. Factor IX. Fibrinogen. Fibrinolysis inhibitors (aminocaproic
acid, tranexamic acid).
BCH 201
2 Unit(s) (LH 30)
At the end of this course, students should be able to: 1. discuss the role of electro transport chain and oxidative phosphorylation in the generation of ATP; 2. define genetic; 3. explain structure of chemistry and funct...
View learning outline
Introduction to Biochemistry. Review of concepts in chemistry applicable to biological systems,
chemical bonds covalent and ionic, biomolecules, elementary thermodynamics, reaction
equilibria. Henderson equation application. Water, physical, biological and chemical
properties. Acid-base chemistry, buffer systems and application to living systems.
Introduction of terms used to describe acid-base disorders in the body, academia, alkalemia,
acidosis and alkalosis. Enzymes, their properties and kinetics. Diversity of biomolecules,
carbohydrates, lipids, proteins, amino acids and nucleic acids in nature. Structure, properties,
and biochemical/biological functions of carbohydrates. Lipids, amino acids, proteins and
nucleic acids.